Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 6
1993 8
1994 6
1995 2
1997 6
1999 3
2000 2
2001 5
2002 4
2003 2
2004 2
2005 1
2006 1
2007 2
2008 1
2009 1
2010 1
2011 1
2012 2
2013 1
2014 2
2015 4
2016 2
2017 2
2018 3
2019 2
2021 6
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, Tesar V, Vanhille P, de Groot K, Luqmani R, Flores-Suarez LF, Watts R, Pusey C, Bruchfeld A, Rasmussen N, Blockmans D, Savage CO, Jayne D; EUVAS investigators. Harper L, et al. Ann Rheum Dis. 2012 Jun;71(6):955-60. doi: 10.1136/annrheumdis-2011-200477. Epub 2011 Nov 29. Ann Rheum Dis. 2012. PMID: 22128076 Clinical Trial.
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO; EUVAS (European Vasculitis Study Group). de Groot K, et al. Ann Intern Med. 2009 May 19;150(10):670-80. doi: 10.7326/0003-4819-150-10-200905190-00004. Ann Intern Med. 2009. PMID: 19451574 Clinical Trial.
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM. Seitz-Polski B, et al. Among authors: esnault vlm. Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24. Clin J Am Soc Nephrol. 2019. PMID: 31340979 Free PMC article. Clinical Trial.
Empagliflozin in Heart Failure.
Gérard AO, Favre G, Esnault VLM. Gérard AO, et al. Among authors: esnault vlm. N Engl J Med. 2021 Jan 28;384(4):386-387. doi: 10.1056/NEJMc2033669. N Engl J Med. 2021. PMID: 33503357 No abstract available.
[Crescentic glomerulonephritis].
Esnault VL, Moreau A, Testa A, Besnier D. Esnault VL, et al. Nephrol Ther. 2006 Dec;2(7):446-60. doi: 10.1016/j.nephro.2006.06.007. Epub 2006 Nov 22. Nephrol Ther. 2006. PMID: 17185236 French.
Cardiovascular Events with Finerenone in CKD and Diabetes.
Gérard AO, Laurain A, Esnault VLM. Gérard AO, et al. Among authors: esnault vlm. N Engl J Med. 2022 Apr 21;386(16):e43. doi: 10.1056/NEJMc2200202. N Engl J Med. 2022. PMID: 35443117 No abstract available.
87 results